David J. Hirst
GlaxoSmithKline
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David J. Hirst.
Angewandte Chemie | 2014
Matthew J. Hesse; Stéphanie Essafi; Charlotte G. Watson; Jeremy N. Harvey; David J. Hirst; Christine L. Willis; Varinder K. Aggarwal
α,α-Disubstituted allylic pinacol boronic esters undergo highly selective allylborations of aldehydes to give tetrasubstituted homoallylic alcohols with exceptional levels of anti-Z-selectivity (>20:1). The scope of the reaction includes both acyclic and cyclic allylic boronic esters which lead to acyclic and exocyclic tetrasubstituted homoallylic alcohols. The use of β-borylated allylic boronic esters gave fully substituted alkenes bearing a boronic ester which underwent further cross-coupling enabling a highly modular and stereoselective approach to the synthesis of diaryl tetrasubstituted alkenes. Computational analysis revealed the origin of the remarkable selectivity observed.
Organic Letters | 2010
Katherine M. Bogle; David J. Hirst; Darren J. Dixon
The total synthesis of (+/-)-powelline (13 linear steps in an overall yield of 6%) and (+/-)-buphanidrine (14 linear steps and a 6% overall yield) and has been achieved using a novel approach to the crinane skeleton. An organocatalytic oxidative coupling allowed direct construction of the key quaternary carbon-to-aryl bond in high yield allowing rapid access to the target alkaloids.
ACS Medicinal Chemistry Letters | 2017
Nicholas Measom; Kenneth David Down; David J. Hirst; Craig Jamieson; Eric S. Manas; Vipulkumar Kantibhai Patel; Donald O. Somers
We describe the incorporation of a bicyclo[1.1.1]pentane moiety within two known LpPLA2 inhibitors to act as bioisosteric phenyl replacements. An efficient synthesis to the target compounds was enabled with a dichlorocarbene insertion into a bicyclo[1.1.0]butane system being the key transformation. Potency, physicochemical, and X-ray crystallographic data were obtained to compare the known inhibitors to their bioisosteric counterparts, which showed the isostere was well tolerated and positively impacted on the physicochemical profile.
Bioorganic & Medicinal Chemistry Letters | 2012
Heng Xu; Haibo Zhang; Linbo Luan; Yan Xu; Chengyong Li; Yonghui Wang; Fangbin Han; Ting Yang; Feng Ren; Jia-Ning Xiang; John D. Elliott; Yonggang Zhao; Taylor B. Guo; Hongtao Lu; Wei Zhang; David J. Hirst; Matthew J Lindon; Xichen Lin
High-throughput screening of GSK compound collection led to the discovery of a novel series of thiadiazole amides as potent and S1P(3)-sparing sphingosine-1-phosphate 1 (S1P(1)) receptor agonists. Synthesis, structure and activity relationship, selectivity, and some developability properties are described.
Journal of Medicinal Chemistry | 2016
Emmanuel Hubert Demont; James Matthew Bailey; Rino A. Bit; Jack A. Brown; Colin A. Campbell; Nigel Deeks; Simon J. Dowell; Colin Eldred; Pam Gaskin; James R. J. Gray; Andrea Haynes; David J. Hirst; Duncan S. Holmes; Umesh Kumar; Mary A. Morse; Greg J. Osborne; Jessica F. Renaux; Gail A. Seal; Chris A. Smethurst; Simon Taylor; Robert J. Watson; Robert Willis; Jason Witherington
FTY720 is the first oral small molecule approved for the treatment of people suffering from relapsing-remitting multiple sclerosis. It is a potent agonist of the S1P1 receptor, but its lack of selectivity against the S1P3 receptor has been linked to most of the cardiovascular side effects observed in the clinic. These findings have triggered intensive efforts toward the identification of a second generation of S1P3-sparing S1P1 agonists. We have recently disclosed a series of orally active tetrahydroisoquinoline (THIQ) compounds matching these criteria. In this paper we describe how we defined and implemented a strategy aiming at the discovery of selective structurally distinct follow-up agonists. This effort culminated with the identification of a series of orally active tetrahydropyrazolopyridines.
Journal of Medicinal Chemistry | 2018
Robert P. Law; Stephen John Atkinson; Paul Bamborough; Chun-wa Chung; Emmanuel Demont; Laurie J. Gordon; Matthew J Lindon; Rab K. Prinjha; Allan J. B. Watson; David J. Hirst
The bromodomain and extra-terminal domain (BET) family of proteins bind acetylated lysine residues on histone proteins. The four BET bromodomains-BRD2, BRD3, BRD4, and BRDT-each contain two bromodomain modules. BET bromodomain inhibition is a potential therapy for various cancers and immunoinflammatory diseases, but few reported inhibitors show selectivity within the BET family. Inhibitors with selectivity for the first or second bromodomain are desired to aid investigation of the biological function of these domains. Focused library screening identified a series of tetrahydroquinoxalines with selectivity for the second bromodomains of the BET family (BD2). Structure-guided optimization of the template improved potency, selectivity, and physicochemical properties, culminating in potent BET inhibitors with BD2 selectivity.
Journal of Organic Chemistry | 2018
Adam W. McCarter; Magdalena Sommer; Jonathan M. Percy; Craig Jamieson; Alan R. Kennedy; David J. Hirst
The intramolecular carbocyclization of difluorinated enol acetals has been achieved for the first time using gold(I) catalysis. Difluorinated enol acetals bearing a pendant alkene group can be cyclized and reduced in one pot to form fluorinated diol motifs. Alternatively, the cyclization of terminal alkynes allows for the synthesis of fluorinated pyran scaffolds. Both cyclization processes can be performed under mild conditions allowing access to complex products rich in functionality. The cyclic systems are synthesized concisely (maximum four steps) from trifluoroethanol, an inexpensive fluorinated feedstock.
Chemistry: A European Journal | 2018
John A. Murphy; Oliver Turner; David J. Hirst; Eric Talbot
Hydrogen atom transfer-mediated intramolecular C-C coupling reactions between alkenes and nitriles, using PhSiH3 and catalytic Fe(acac)3 , are described. This introduces a new strategic bond disconnection for ring-closing reactions, forming ketones via imine intermediates. Of note is the scope of the reaction, including formation of sterically hindered ketones, spirocycles and fused cyclic systems.
Chemistry: A European Journal | 2015
Jonathan M. Percy; Adam W. McCarter; Alan L. Sewell; Nikki Sloan; Alan R. Kennedy; David J. Hirst
Palladium(II)-catalysed cycloalkenylation (Saegusa-Ito cyclisation) has been used for the first time to transform difluorinated silylenol ethers to difluorinated cycloalkenones under mild conditions. The silylenol ether precursors were prepared in two high-yielding steps from trifluoroethanol, and cyclised in moderate to good yields. A combination of air and copper(I) chloride in acetonitrile gave the turnover of the initial palladium(II) salt, whereas the provision of an oxygen atmosphere ensured more rapid reaction. Annulations required a minimum level of substitution on the chain, but failed when the alkene was substituted. Annelations allowed a range of n,6-bicyclic systems to be prepared and afforded three products, in which heterocycles were fused to the new cyclohexenone. The least substituted system explored underwent cyclisation followed by terminal oxidation to a cyclic enal, which corresponded to a Wacker product of unusual regiochemistry.
Organic Letters | 2007
Katherine M. Bogle; David J. Hirst; Darren J. Dixon